Central Garden & Pet Stock (NASDAQ: CENTA)

Dernières nouvelles pour Central Garden & Pet (NASDAQ:CENTA) Stock

Central Garden & Pet

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Central Garden & Pet Company - Class A Common Stock Nonvoting

Central Garden & Pet Co

CENTAMIN ORD

Centamin PLC

Centaur Media PLC

CENTAURUS ENERGY INC by Centaurus Energy Inc.

Centaurus Energy Inc

CENTAURUS METALS LTD ORD by Centaurus Metals Ltd.

Centaurus Metals Ltd

In late 2023, many analysts called for 2024 to be the year of a small-cap stock renaissance. These stocks were battered as the Federal Reserve aggressively raised interest rates. Many of these companies rely on borrowing to fund their growth and struggled as the cost of borrowing increased.&nbsp;
The Russell 2000 index, which tracks many small-cap stocks, is up 20% in 2024. But not all small-cap stocks participated in that rally. However, with the Federal Reserve suggesting that its 50-basis point cut in September was the first in a series of future rate cuts, borrowing conditions should improve for small-cap stocks, particularly those that already show solid fundamentals like the stocks mentioned here. &nbsp;
Analysts are projecting earnings growth of at least 10% in the next 12 months for each of these companies. That growth and other catalysts make these stocks strong candidates to outperform the market in the next 12 months. &nbsp;
<h2>Star Bulk Carriers Will Benefit From China&#39;s Stimulus Measures&nbsp;</h2>
Dry bulk carrier stocks aren&#39;t the most exciting. But Star Bulk Carriers Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sblk#NASDAQ">SBLK</a>) is one to watch heading into 2025. It&#39;s the largest U.S.-listed dry bulk company with a fleet of 160 vessels. The company also has a strong balance sheet and has been paying down debt at a rate of about $250 million per year, a pace it expects to continue to match in the future.
However, a key reason for the company&#39;s short-term growth will likely come from China. The company has noted that dry bulk shipments to China were up about 7.5% in the first seven months of 2024. That was before the company announced new stimulus measures, which will likely increase demand for imports of raw materials like iron ore.&nbsp;&nbsp;
Then, you have to consider the company&#39;s valuation. SBLK stock is trading at just 6.9x forward earnings. The stock is up 7.6% in 2024, but analysts have a consensus price target of $29.33 which gives investors about 28% upside to go along with a dividend that has a 12.2% yield. The one risk is higher oil prices which would hurt earnings. &nbsp;
<h2>Evolv Technologies Is a Play on the Application of AI&nbsp;</h2>
Unfortunately, the nation experienced another school shooting in September. Perhaps anecdotally, the share price of Evolv Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evlv#NASDAQ">EVLV</a>) is up 59% in the 90 days ending October 3, 2024. Evolv provides a next-generation metal detection system that is rooted in artificial intelligence (AI).
A key benefit of the company&#39;s Evolv Express system is that it provides a truly touchless security screening system. This allows an uninterrupted traffic flow into and out of the venues in which it operates. In fact, the company&#39;s technology has screened over one billion people since 2019. &nbsp;
The company&#39;s products are used by one or more teams in every professional sports league. Evolv&#39;s customer base also includes hospitals, churches, and school systems that are looking for a non-invasive way to screen for firearms, explosives, and tactical knives. &nbsp;
However, even with the sharp move higher in the last three months, EVLV stock is still down 17.3% for the year and over 15% in the last 12 months. One concern is earnings. The company just posted its first profitable quarter. Another concern is competition. However, the company&#39;s annual recurring revenue (ARR) continues to rise, suggesting this concern may be overstated. &nbsp;
<h2>Central Garden &amp; Pet Company May Be an Undiscovered Gem&nbsp;</h2>
Last on this list of small-cap stocks poised for growth in 2025 is Central Garden &amp; Pet Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/centa#NASDAQ">CENTA</a>). As its name suggests, the company&#39;s business is divided into two verticals. Its garden sector offers a range of lawn and garden supplies, while its Pet sector provides supplies for dogs, cats, and other pets.
Like many consumer discretionary stocks, CENTA stock lags the broader market. However, it&#39;s still up about 3.8% in 2024. This comes as the company is showing a slight decline in the top line, which is offset by earnings that are growing year-over-year.&nbsp;
However, the company points to its customer base which continues to spend on their pets. The company has also taken steps in its garden division to navigate through external challenges that are a constant in the business. &nbsp;
The CENTA analyst forecasts on MarketBeat show bullish sentiment for the stock. The $42 consensus price target gives the stock an upside of 43%. &nbsp;
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/3-small-cap-stocks-on-the-way-to-bigger-and-better-days/">3 Small-Cap Stocks on the Way to Bigger and Better Days</a>&quot; first appeared on MarketBeat.

Earnings

Mid Cap

News

Penny Stocks

Dividends

Price Target

Small Cap

Federal Reserve

Markets

Analyst Ratings

Tech

Trading Ideas

CENTA

EVLV

SBLK

3 Small-Cap Stocks on the Way to Bigger and Better Days

Niko Lahanas, Former Central CFO, Brings 18 Years of Experience at the Company
Brad Smith, Former CFO, Pet Segment, Appointed Central CFO
Interim CEO and Director Beth Springer to Return to Role of Lead Independent Director
Central Garden &amp; Pet Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>), (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>), ("Central" or "the Company"), a market leader in the Pet and Garden industries, announced today that <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fniko-lahanas%2F&amp;esheet=54127962&amp;newsitemid=20240927935178&amp;lan=en-US&amp;anchor=Niko+Lahanas&amp;index=1&amp;md5=c5360414556d7108604d77cecea22146">Niko Lahanas</a> has been appointed Chief Executive Officer, and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fbradleygsmith8%2F&amp;esheet=54127962&amp;newsitemid=20240927935178&amp;lan=en-US&amp;anchor=Brad+Smith&amp;index=2&amp;md5=ea7f3ee9d4b415755d8ba616d59cc1b7">Brad Smith</a> has been appointed Chief Financial Officer, effective September 29, 2024. Mr. Lahanas will also join Central's Board of Directors. Mr. Lahanas succeeds Beth Springer, who has served as Interim Chief Executive Officer since October, 2023. Ms. Springer will return to the role of Lead Independent Director.

Management

CENT

Central Garden & Pet Appoints Niko Lahanas As CEO And Brad Smith As CFO; Interim CEO And Director Beth Springer To Return To Role Of Lead Independent Director

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our<a href="https://www.benzinga.com/analyst-stock-ratings"> analyst ratings page.</a>
<ul>
<li>Canaccord Genuity cut the price target for Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) from $23 to $18. Canaccord Genuity analyst Michael Graham maintained a Buy rating. Lyft shares fell 17.2% to close at $9.08 on Wednesday. <a href="https://www.benzinga.com/quote/LYFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wedbush slashed the price target for Dine Brands Global, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIN#NYSE">DIN</a>) from $37 to $34. Wedbush analyst Nick Setyan maintained the stock with a Neutral rating. Dine Brands Global shares fell 4.6% to close at $30.44 on Wednesday. <a href="https://www.benzinga.com/quote/DIN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler raised Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) price target from $144 to $147. Piper Sandler analyst Peter Keith maintained an Overweight rating. Boot Barn shares fell 1.6% to close at $115.70 on Wednesday. <a href="https://www.benzinga.com/quote/BOOT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut the price target for Central Garden &amp; Pet Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) from $38 to $34. JP Morgan analyst Andrea Faria Teixeira maintained a Neutral rating. Central Garden shares fell 1.1% to close at $32.70 on Wednesday. <a href="https://www.benzinga.com/quote/CENTA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley cut Bumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) price target from $12 to $6. Morgan Stanley analyst Nathan Feather maintained an Equal-Weight rating. Bumble shares rose 1.9% to close at $8.06 on Wednesday. <a href="https://www.benzinga.com/quote/BMBL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities boosted Editas Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) price target from $13 to $15. B of A Securities analyst Greg Harrison upgraded the stock from Neutral to Buy. Editas Medicine shares fell 12.2% to close at $4.11 on Wednesday. <a href="https://www.benzinga.com/quote/EDIT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities raised the price target for PetIQ, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETQ#NASDAQ">PETQ</a>) from $30 to $31. Truist Securities analyst Bill Chappell downgraded the stock from Buy to Hold. PetIQ shares gained 47.9% to close at $30.42 on Wednesday. <a href="https://www.benzinga.com/quote/PETQ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) price target from $145 to $110. Needham analyst Laura Martin maintained a Buy rating. Disney shares fell 4.5% to close at $85.96 on Wednesday. <a href="https://www.benzinga.com/quote/DIS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird slashed Charles River Laboratories International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) price target from $239 to $191. Baird analyst Eric Coldwell downgraded the stock from Outperform to Neutral. Charles River Laboratories shares fell 12.6% to close at $199.96 on Wednesday. <a href="https://www.benzinga.com/quote/CRL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird cut McKesson Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) price target from $694 to $671. Baird analyst Eric Coldwell maintained an Outperform rating. McKesson shares gained 0.5% to close at $617.51 on Wednesday. <a href="https://www.benzinga.com/analyst-stock-ratings">See how other analysts view this stock.</a></li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40243140/us-stocks-decline-as-smcis-margin-miss-brings-nvidia-and-other-ai-stocks-under-pressure-investor-se">US Stocks Decline As SMCI&#8217;s Margin Miss Brings Nvidia And Other AI Stocks Under Pressure: Investor Sentiment Remains In &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

BMBL

BOOT

EDIT

LYFT

PETQ

Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday

JP Morgan analyst Andrea Faria Teixeira maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) with a Neutral and lowers the price target from $38 to $34.

JP Morgan Maintains Neutral on Central Garden & Pet, Lowers Price Target to $34

Guidance

Central Garden & Pet Sees FY24 Adj. EPS $2.00 Or Better Vs $2.19 Est.

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.20 by 10 percent. The company reported quarterly sales of $996.348 million which missed the analyst consensus estimate of $1.002 billion by 0.52 percent. This is a 2.61 percent decrease over sales of $1.023 billion the same period last year.

Earnings Beats

Earnings Misses

Central Garden & Pet Q3 2024 Adj. EPS $1.32 Beats $1.20 Estimate, Sales $996.348M Miss $1.002B Estimate

JP Morgan analyst Andrea Faria Teixeira maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) with a Neutral and lowers the price target from $40 to $38.

JP Morgan Maintains Neutral on Central Garden & Pet, Lowers Price Target to $38

Truist Securities analyst Bill Chappell maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) with a Buy and raises the price target from $45 to $50.

Truist Securities Maintains Buy on Central Garden & Pet, Raises Price Target to $50

Fiscal 2024 Guidance
Central continues to expect fiscal 2024 non-GAAP EPS to be $2.00 or better ($2.50 or better before the February 2024 stock dividend).
This outlook reflects uncertain consumer demand and retailer dynamics and an environment of macroeconomic and geopolitical volatility. It includes modest carryover pricing actions to help mitigate inflationary headwinds. This outlook excludes the impact of any acquisitions, divestitures or restructuring activities that may occur during fiscal 2024, including any projects under the Cost and Simplicity program and the recent TDBBS acquisition. Central expects fiscal 2024 capital spending to be approximately $70 million.

Central Garden & Pet Continues To Expect FY24 Non-GAAP EPS To Be $2.00 Or Better ($2.50 Or Better Before The February 2024 Stock Dividend) Vs $2.23 Est

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.80 by 23.75 percent. The company reported quarterly sales of $900.000 million which beat the analyst consensus estimate of $887.420 million by 1.42 percent. This is a 0.99 percent decrease over sales of $909.004 million the same period last year.

Central Garden & Pet Q2 2024 Adj EPS $0.99 Beats $0.80 Estimate, Sales $900.000M Beat $887.420M Estimate

Truist Securities analyst Bill Chappell maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) with a Buy and raises the price target from $50 to $60.

Truist Securities Maintains Buy on Central Garden & Pet, Raises Price Target to $60-Report released on 8th February 2024

JP Morgan analyst Andrea Faria Teixeira maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) with a Neutral and raises the price target from $40 to $43.

JP Morgan Maintains Neutral on Central Garden & Pet, Raises Price Target to $43

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.17) by 105.88 percent. The company reported quarterly sales of $634.53 million which beat the analyst consensus estimate of $619.95 million by 2.35 percent. This is a 1.09 percent increase over sales of $627.66 million the same period last year.

Central Garden & Pet Q1 2024 GAAP EPS $0.01 Beats $(0.17) Estimate, Sales $634.53M Beat $619.95M Estimate

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) reported its Q1 earnings results on Wednesday, February 7, 2024 at 04:03 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Central Garden &amp; Pet beat estimated earnings by 105.88%, reporting an EPS of $0.01 versus an estimate of $-0.17.
Revenue was up $6.87 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.18 which was followed by a 0.84% drop in the share price the next day.
Here's a look at Central Garden &amp; Pet's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.07</td>
<td>0.07</td>
<td>1.35</td>
<td>1.45</td>
<td>0.94</td>
<td>0.94</td>
<td>-0.17</td>
<td>-0.17</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>0.10</td>
<td>1.75</td>
<td>1.75</td>
<td>0.90</td>
<td>0.90</td>
<td>-0.16</td>
<td>-0.16</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>735.32M</td>
<td>735.32M</td>
<td>932.78M</td>
<td>1.03B</td>
<td>899.17M</td>
<td>899.17M</td>
<td>620.30M</td>
<td>620.30M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>750.15M</td>
<td>750.15M</td>
<td>1.02B</td>
<td>1.02B</td>
<td>909.00M</td>
<td>909.00M</td>
<td>627.66M</td>
<td>627.66M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Central Garden &amp; Pet <a href="https://www.benzinga.com/quote/CENTA/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Central Garden & Pet Q1 Earnings

ACLS

ADNT

ALCO

APPS

ARCC

ASGN

ASND

AVXL

AZTA

BABA

BARK

BERY

BLBD

CDAY

CFLT

CMRE

COTY

CRTO

CSGS

EEFT

ENTA

EQNR

FLNC

FLNG

FORM

FOXA

GEOS

GPRE

GPRO

HAIN

INTR

MCFT

MKSI

MPWR

MSGE

MTRX

NBIX

NOTV

NTGR

NVST

NWSA

OESX

ORLY

OSCR

PAHC

Earnings Scheduled For February 7, 2024

WIIM

Central Garden & Pet shares are trading lower after the company reported Q4 financial results and issued FY24 adjusted EPS guidance below estimates.

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) reported its Q4 earnings results on Monday, November 20, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Central Garden &amp; Pet beat estimated earnings by 42.86%, reporting an EPS of $0.1 versus an estimate of $0.07.
Revenue was up $42.70 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.03 which was followed by a 0.3% drop in the share price the next day.
Here's a look at Central Garden &amp; Pet's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.35</td>
<td>1.45</td>
<td>0.94</td>
<td>0.94</td>
<td>-0.17</td>
<td>-0.17</td>
<td>0.01</td>
<td>0.01</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.75</td>
<td>1.75</td>
<td>0.90</td>
<td>0.90</td>
<td>-0.16</td>
<td>-0.16</td>
<td>-0.04</td>
<td>-0.04</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>932.78M</td>
<td>1.03B</td>
<td>899.17M</td>
<td>899.17M</td>
<td>620.30M</td>
<td>620.30M</td>
<td>719.67M</td>
<td>719.67M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.02B</td>
<td>1.02B</td>
<td>909.00M</td>
<td>909.00M</td>
<td>627.66M</td>
<td>627.66M</td>
<td>707.44M</td>
<td>707.44M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Central Garden &amp; Pet <a href="https://www.benzinga.com/quote/CENTA/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Central Garden & Pet Q4 Earnings

<h3>Companies Reporting Before The Bell</h3>
&bull; Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.
&bull; Pyxis Tankers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXS#NASDAQ">PXS</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $8.25 million.
&bull; BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) is estimated to report earnings for its third quarter.
&bull; ReNew Energy Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNW#NASDAQ">RNW</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $109.71 million.
&bull; So-Young Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $55.38 million.
&bull; Enlight Renewable Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLT#NASDAQ">ENLT</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $65.70 million.
&bull; Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>) is projected to report earnings for its third quarter.
&bull; Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $179.52 million.
&bull; Full Truck Alliance Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMM#NYSE">YMM</a>) is projected to report earnings for its third quarter.
&bull; VEON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) is expected to report earnings for its third quarter.
&bull; Fanhua (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANH#NASDAQ">FANH</a>) is expected to report earnings for its third quarter.
&bull; Niu Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIU#NASDAQ">NIU</a>) is expected to report earnings for its third quarter.
<h3>Companies Reporting After The Bell</h3>
&bull; Techprecision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPCS#NASDAQ">TPCS</a>) is expected to report earnings for its second quarter.
&bull; Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) is likely to report quarterly loss at $0.16 per share on revenue of $3.40 million.
&bull; Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $735.32 million.
&bull; Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $735.32 million.
&bull; Remark Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARK#NASDAQ">MARK</a>) is estimated to report earnings for its third quarter.
&bull; Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) is projected to report earnings for its third quarter.
&bull; Polished.com (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/POL#AMEX">POL</a>) is likely to report earnings for its third quarter.
&bull; Upexi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) is expected to report quarterly loss at $0.04 per share on revenue of $26.52 million.
&bull; Enanta Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTA#NASDAQ">ENTA</a>) is expected to report quarterly loss at $2.00 per share on revenue of $20.60 million.
&bull; Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is estimated to report earnings for its third quarter.
&bull; Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $305.16 million.
&bull; FinVolution Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINV#NYSE">FINV</a>) is likely to report earnings for its third quarter.
&bull; Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) is estimated to report earnings for its third quarter.
&bull; Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) is estimated to report quarterly earnings at $1.87 per share on revenue of $1.30 billion.
&bull; Fidelis Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIHL#NYSE">FIHL</a>) is projected to report earnings for its third quarter.
&bull; Zoom Video Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) is projected to report quarterly earnings at $1.08 per share on revenue of $1.12 billion.
&bull; BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) is likely to report quarterly earnings at $0.39 per share on revenue of $460.52 million.
&bull; FS Credit Opp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSCO#NYSE">FSCO</a>) is expected to report earnings for its third quarter.
&bull; Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) is projected to report quarterly earnings at $1.35 per share on revenue of $1.68 billion.
&bull; Golub Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBDC#NASDAQ">GBDC</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $157.82 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

BLRX

BRBR

ENLT

FANH

FIHL

FINV

FSCO

GBDC

GTEC

KEYS

LEGN

MARK

PRST

TCOM

TPCS

UPXI

VEON

XELB

YALA

ZEPP

Earnings Scheduled For November 20, 2023

Acquisition Builds Scale and Adds eCommerce and Digital Capabilities to Core Pet Category
Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) ("Central"), a market leader in the Pet and Garden industries, announced today that it has acquired TDBBS, LLC ("TDBBS") from Bregal Partners. Based in Richmond, VA, TDBBS is a provider of premium natural dog chews and treats. The addition of TDBBS will expand Central's portfolio with bully and collagen sticks, bones and jerky, and further strengthen Central's eCommerce and digital capabilities.
"We are excited to welcome the TDBBS team into the Central Garden &amp; Pet organization," said Beth Springer, Interim CEO of Central. "Our Central to Home strategy is focused on building further scale in our two industries and growing leading brands consumers love. Adding TDBBS's established brands and digital capabilities solidifies our position in the large and growing dog treats and chews category and will strengthen our footprint with key customers."
Since 2008, TDBBS has developed and sold minimally processed dog treats and chews. Each of their three well-known brands (Best Bully Sticks&#xAE;, Barkworthies&#xAE; and Paw Love&#xAE;) offers a wide variety of natural, grain and gluten-free products that are low in fat and high in protein and made from limited ingredients. Their wholesome treats and chews keep dogs occupied while promoting overall health.
A pioneer in eCommerce, TDBBS was founded as a digitally native brand with a first-mover advantage. Today, the company's brands and websites are synonymous with the bully stick category. TDBBS sells its products online direct-to-consumer and through third-party platforms, as well as through pet specialty and select grocery, mass and club retailers.
"For over 15 years, TDBBS has been proud to offer the widest selection of high-quality natural dog treats and chews. We believe pets are family, and they deserve quality ingredients just like us. We are excited for this next chapter in our business as part of Central Garden &amp; Pet," said Tom Goundrey, CEO of TDBBS. "Central's resources, capabilities and expertise in the pet industry will be key to growing our business further."
Central was represented by Orrick as legal advisor. TDBBS was represented by Lazard as exclusive financial advisor and Dechert as legal advisor.
The transaction closed on November 3, 2023. Central will provide additional details on the acquisition during its fourth quarter and fiscal year-end earnings call later in November.

Central Garden & Pet Acquires Pet Treat Company TDBBS; No Financial Terms Disclosed

Keybanc analyst Bradley Thomas maintains Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) with a Overweight and raises the price target from $46 to $50.

Keybanc Maintains Overweight on Central Garden & Pet, Raises Price Target to $50

Canaccord Genuity analyst Brian McNamara maintained a Buy rating on Central Garden Pet (CENT – Research Report) yesterday and set a price target of...

Buy Rating Affirmed for Central Garden & Pet on Strong Q2 Results and Strategic Growth Prospects

Spectrum Brands Holdings: Still Attractive If You Can Handle It

In a report released on July 18, Andrea Faria Teixeira from J.P. Morgan maintained a Hold rating on Central Garden Pet (CENT – Research Report), wi...

J.P. Morgan Remains a Hold on Central Garden Pet (CENT)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Central Garden &amp; Pet (NASDAQ:<a href="https://investorplace.com/stock-quotes/centa-stock-quote/">CENTA</a>) just reported results for the third quarter of 2024.<ul><li>Central Garden &amp; Pet reported earnings per share of $1.32. This was above the analyst estimate for EPS of $1.20.</li><li>The company reported revenue of $996.35 million.</li><li>This was 0.37% worse than the analyst estimate for revenue of $1.00 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/centa-stock-earnings-central-garden-pet-for-q3-of-2024/">CENTA Stock Earnings: Central Garden &amp; Pet Beats EPS, Misses Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CENTA Stock Earnings: Central Garden & Pet Beats EPS, Misses Revenue for Q3 2024

Brian McNamara, an analyst from Canaccord Genuity, maintained the Buy rating on Central Garden Pet (CENT – Research Report). The associated price t...

Central Garden & Pet (CENT) Poised for Growth Amid Strategic Initiatives and Cost Reductions

Central Garden & Pet Company 2024 Q3 - Results - Earnings Call Presentation

Central Garden & Pet Company (CENT) Q3 2024 Earnings Call Transcript

Central Garden & Pet names new CEO, CFO

In a report released on September 27, Brian McNamara from Canaccord Genuity maintained a Buy rating on Central Garden Pet (CENT – Research Report),...

Strategic Leadership and Financial Strength Underpin Buy Rating for Central Garden Pet

Warning: CENTA is at high risk of performing badly

REYN

WDFC

Press Releases

Central Garden & Pet to Participate in a Fireside Chat at the Virtual Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference

Outdoor Furniture Cushion Brand ARDEN Partners with Country Music Singer & Songwriter Alexandra Kay to Launch "Favorites" Collection Ahead of Summer Patio Season

Aqueon® Launches BlueIQ™ App for Smart and Easy Aquarium Care

Nylabone Sponsors Reunification of Retired Military Dog with Former Handler

Central Garden & Pet to Announce Q3 Fiscal 2024 Financial Results

Barkworthies Offers More Variety and Value with New Single-Count Options in Hickory Smoked Line

Central Garden & Pet Announces Q3 Fiscal 2024 Financial Results

Central Garden & Pet to Participate in the Barclays 17th Annual Global Consumer Staples Conference

Nylabone Named a 2024-2025 Top Performer by Pet Sustainability Coalition

Central Garden & Pet Appoints Niko Lahanas as CEO and Brad Smith as CFO

Central Garden & Pet Company - Common Stock

Church & Dwight Company, Inc. Common Stock

Church & Dwight Co

Colgate-Palmolive

Clorox

Energizer Hldgs

Kimberly-Clark

Oil-Dri Corporation Of America Common Stock

Oil-Dri Corp of America

Procter & Gamble Company (The) Common Stock

Procter & Gamble

Reynolds Consumer Products Inc. - Common Stock

Reynolds Consumer Prods

Spectrum Brands Holdings, Inc. Common Stock

Spectrum Brands Holdings

WD-40

Canaccord Genuity

JP Morgan

Argus Research

Truist Securities

Keybanc

Comments

Central Garden & Pet

Actualités

Dernières nouvelles pour Central Garden & Pet (NASDAQ:CENTA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL